Surgery Partners Inc(SGRY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 29 at 4:00 PM ET (Korea 10/30 05:00)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.69 | Insider Own | 40.42% | Shs Outstand | 130.9M | Perf Week | 45.97% |
| Market Cap | 2.99B | Forward P/E | 64.97 | EPS next Y | 0.64% | Insider Trans | 0.02% | Shs Float | 76.8M | Perf Month | 67.34% |
| Enterprise Value | 8.63B | PEG | 13.62 | EPS next Q | 0.11 | Inst Own | 87.98% | Short Float | 18.67% | Perf Quarter | 50.71% |
| Income | -0.09B | P/S | 0.89 | EPS this Y | -24.47% | Inst Trans | 1.07% | Short Ratio | 4.35 | Perf Half Y | 65.43% |
| Sales | 3.37B | P/B | 1.82 | EPS next 5Y | 4.77% | ROA | -1.11% | Short Interest | 14.33M | Perf YTD | 50.23% |
| Book/sh | 12.76 | P/C | 13.8 | EPS past 3/5Y | -1.03% 28.11% | ROE | -5.18% | 52W High | -0.98% ($23.44) | Perf Year | 1.98% |
| Cash/sh | 1.68 | P/FCF | 15.94 | Sales past 3/5Y | 9.22% 12.21% | ROIC | -1.59% | 52W Low | 103.42% ($11.41) | Perf 3Y | 3.52% |
| Dividend Est. | - | EV/EBITDA | 13.57 | EPS Y/Y TTM | 51.58% | Gross Margin | 17.25% | Volatility(W/M) | 2.14% 3.6% | Perf 5Y | -43.58% |
| Dividend TTM | - | EV/Sales | 2.56 | Sales Y/Y TTM | 3.99% | Oper. Margin | 13.64% | ATR (14) | 0.93 | Perf 10Y | 42.74% |
| Dividend Ex-Date | - | Quick Ratio | 1.78 | EPS Q/Q | -490.86% | Profit Margin | -2.63% | RSI (14) | 86.16 | Recom | 2.43 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.95 | Sales Q/Q | 2.75% | SMA20 | 43% ($16.23) | Beta | 1.99 | Target Price | $22.08 |
| Payout | - | Debt/Eq | 2.43 | Earnings | 2026/8/10 | SMA50 | 55.3% ($14.95) | Rel Volume | 1.01 | Prev Close | $23.24 |
| Employees | 16000 | LT Debt/Eq | 2.34 | EPS/Sales Surpr. | 72.71% 2.27% | SMA200 | 59.1% ($14.59) | Avg Volume(3M) | 3.29M | Price | $23.21 |
| IPO | 2015/10/1 | Option/Short | Yes/Yes | Trades | 10554 | Volume | 3,320,905 | Change | -0.13% |
🏥 A U.S. healthcare company that operates outpatient surgery centers and surgical facilities. In collaboration with physicians, it runs outpatient surgery centers and short-stay surgical hospitals, providing ambulatory surgical services that can be performed without hospital admission. The company has established itself as a surgical facility operator that combines a cost-efficient outpatient surgery model with physician partnerships.
Over the past 1 year, on the higher side
1% below its 1-year high.
Traded about as much as usual. That is 101% of its average volume.
SGRY keeps an operating profit but posts a net loss
Of every $100 in sales, $13.64 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -24.5% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $89. Peers typically go for $89.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -43.6%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 88.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
XHS State Street SPDR S&P Health Care Services ETF 0.02% 
XCCC BondBloxx CCC-Rated USD High Yield Corporate Bond ETF 0.01% 
XHYH BondBloxx USD High Yield Bond Healthcare Sector ETF 0.01% 
HYDB iShares High Yield Systematic Bond ETF <0.01% 
IBHL iShares iBonds 2032 Term High Yield and Income ETF <0.01% It ranks #14 of 48 in the industry
Based on market cap of $3B.
FAQ
What kind of company is SGRY?
SGRY belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of SGRY?
The market cap of SGRY is approximately $3.0B, ranking 1,770 within its sector.
What is the 52-week high and low for SGRY?
SGRY has recorded a 52-week high of $23.44 and a low of $11.41.
